0001104659-23-031929.txt : 20230313 0001104659-23-031929.hdr.sgml : 20230313 20230313204612 ACCESSION NUMBER: 0001104659-23-031929 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230309 FILED AS OF DATE: 20230313 DATE AS OF CHANGE: 20230313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NORTHSTAR BIO VENTURES, LLC CENTRAL INDEX KEY: 0001884591 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40861 FILM NUMBER: 23728908 BUSINESS ADDRESS: STREET 1: 117 STATE STREET, 21ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10004 BUSINESS PHONE: 917-267-0216 MAIL ADDRESS: STREET 1: 117 STATE STREET, 21ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10004 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Monterey Innovation Acquisition Corp CENTRAL INDEX KEY: 0001860663 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 852204842 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 17 STATE STREET STREET 2: 21ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10004 BUSINESS PHONE: 917-267-0216 MAIL ADDRESS: STREET 1: 17 STATE STREET STREET 2: 21ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10004 FORMER COMPANY: FORMER CONFORMED NAME: Monterey Bio Acquisition Corp DATE OF NAME CHANGE: 20210505 4 1 tm239467-10_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2023-03-09 0 0001860663 Monterey Innovation Acquisition Corp MTRY 0001884591 NORTHSTAR BIO VENTURES, LLC C/O MONTEREY INNOVATION ACQUISITION CORP. 17 STATE STREET, 21ST FLOOR NEW YORK NY 10004 0 0 1 0 Common Stock 2023-03-09 4 S 0 570000 0.006 D 1342500 D Common Stock 2023-03-09 4 J 0 75000 A 1417500 D This Form 4 is being filed by NorthStar Bio Ventures, LLC (the "NorthStar Co-Sponsor"). Sandip I. Patel is a manager of NorthStar Co-Sponsor. Accordingly, Mr. Patel has voting and dispositive power over the shares of common stock (the "founder shares") of Monterey Innovation Acquisition Corp. (the "Company") held by NorthStar Co-Sponsor and may be deemed to beneficially own such shares. Mr. Patel disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. In connection with the Company's previously disclosed management transition, and pursuant to share transfer agreements dated March 9, 2023, NorthStar Co-Sponsor transferred (i) 478,125 founder shares to Chardan Monterey Investments LLC and (ii) 30,625 founder shares to each of the Company's three new directors, in each case, at a price of $0.006 per share. On March 9, 2023, Sanjeev Satyal resigned as the Company's Chief Executive Officer and, pursuant to an assignment dated March 9, 2023, transferred back to NorthStar Co-Sponsor 75,000 of the founder shares that he received from NorthStar Co-Sponsor prior to the Company's initial public offering. NorthStar Bio Ventures, LLC By: /s/ Jason T. Simon, as Attorney-in-Fact 2023-03-13